CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
ASSETS
Cash and cash equivalents, $3,751 reserved at March 31, 2013	$ 9,201	$ 10,205
Other current assets	305	383
Total current assets	9,506	10,588
Patent license rights, net	941	980
Furniture and equipment, net	13	23
Total assets	10,460	11,591
LIABILITIES AND EQUITY
Accounts payable	313	233
Other accrued liabilities	21	61
Total current liabilities	334	294
Equity
Common Stock $.0005 par value; 100,000,000 shares authorized; 40,885,411 shares in 2013 and 2012 issued and outstanding	20	20
Additional paid-in capital	189,198	189,181
Accumulated deficit ($151,330 at March 31, 2013 and $150,335 at December 31, 2012, accumulated during development stage period)	(179,092)	(178,097)
Total Capstone Therapeutics Corp. stockholders' equity	10,126	11,104
Noncontrolling interest	0	193
Total equity	10,126	11,297
Total liabilities and equity	$ 10,460	$ 11,591